Garmin is now facing a legal test over a familiar consumer-tech problem: when a device estimates the body, how precise can the marketing sound before it becomes misleading?
A 56-page class-action complaint filed in the United States District Court for the Northern District of Illinois accuses Garmin of overstating what the Garmin Index S2 smart scale can accurately measure, according to Notebookcheck. The case centers on claims that the scale can accurately assess body composition metrics, with plaintiff Victor Maurer alleging that after buying the scale in August 2024, he found major differences between its readings and values from a DEXA scan.
The lawsuit is not just about one bathroom scale. It asks whether connected health brands can sell modeled outputs as if they are measurements. That distinction matters because the Index S2 uses bioelectrical impedance analysis, a method that carries obvious limits when implemented through foot electrodes alone.
Garmin Index S2 lawsuit turns a fitness-scale feature into a truth-in-advertising test
The complaint targets Garmin’s marketing around the Index S2, not merely the existence of measurement error. That is the sharper issue. Consumer devices can be imperfect. The legal risk grows when the company’s language allegedly encourages buyers to treat indirect estimates as accurate body-composition analysis.
Notebookcheck reports that the complaint points to the technical limits of a two-foot-electrode setup and cites two studies. The lawsuit seeks an end to the marketing it describes as misleading, along with financial compensation, including legal fees.
“Whether Garmin actually acted improperly will likely only be determined through legal proceedings, but the allegation does not appear to be entirely unfounded,” Notebookcheck wrote.
That last phrase is doing real work. The source is not declaring Garmin liable. It is saying the technical criticism has a plausible basis: a foot-to-foot scale has a constrained measurement path.
For readers tracking Garmin’s broader hardware activity, this dispute sits apart from product-cycle news like Garmin A04831 Filing Pits Tacx Trainer Against Edge 1060 or leaks such as Bluetooth-only Garmin CIRQA. The issue here is not what Garmin might launch next. It is how Garmin describes what an existing device can know.
A foot-to-foot current is the technical weak point
Bioelectrical impedance analysis uses electrical current to estimate body composition. In a scale without hand sensors, that current travels through the lower body, effectively from one leg to the other. That means the device is better positioned to assess the electrical properties along that path than to directly measure the full body.
That is the technical hinge of the lawsuit. A smart scale that measures through the feet is more likely to reflect lower-body body fat percentage than total body fat percentage, according to the source material. From there, the device’s body-composition output depends on inference.
This does not make the metric useless. Trend tracking can still have value. If the same person measures repeatedly under similar conditions, directional changes may tell a useful story. But the source flags the core problem: fat distribution varies from person to person, and exact body-fat analysis is “anything but trivial.”
The comparison with clinical or manual methods matters:
| Method | What the source supports | Practical limitation |
|---|---|---|
| Foot-to-foot smart scale | Uses BIA and a lower-body electrical path | May reflect lower-body composition more than total-body composition |
| DEXA scan | Used as Maurer’s comparison point; requires specialized equipment | Not a casual home method |
| Caliper measurements | Can be done privately with effort | Still subject to deviations |
MLXIO analysis: Garmin’s likely technical problem is not that the Index S2 estimates. The problem is whether buyers were led to believe the estimate carried more whole-body accuracy than the measurement setup can support.
The useful numbers are in the complaint, not Garmin’s accuracy claims
The available source material gives legal numbers, not performance numbers. That distinction matters.
Known figures from the source:
- 56-page complaint: The class-action filing is substantial enough to lay out technical and marketing arguments in detail.
- August 2024 purchase: Plaintiff Victor Maurer allegedly bought the scale then.
- Two studies cited: The complaint uses outside research to support its criticism of the measurement method.
- One named comparison method: Maurer compared the Index S2 results with a DEXA scan.
What the source does not provide is just as important. It does not give the exact size of Maurer’s reported discrepancy. It does not list every body-composition metric at issue. It does not quote Garmin’s full marketing language. It does not state whether Garmin has responded.
That limits any responsible analysis. We can say the case challenges accuracy claims around body-composition metrics. We cannot say from this source how inaccurate the device allegedly was, how many customers were affected, or what Garmin’s defense will be.
This is where the lawsuit becomes a precision test for journalism, too. The technical theory is plausible. The legal merits remain unproven.
Buyers, Garmin and the court are likely to fight over the same word: “accurate”
The central dispute will likely narrow to one word: accurate.
From a buyer’s perspective, “accurate” may imply that the scale can meaningfully assess total body composition, not merely provide a directional estimate shaped by lower-body electrical readings. That expectation becomes stronger when a product is marketed as a smart health device rather than a simple weight scale.
Garmin may argue, if it contests the claim, that consumer smart-scale readings are inherently estimates, that limitations are disclosed, or that reasonable users understand wellness devices are not clinical diagnostics. Those are possible defense themes, not established facts from the source.
The court’s job will be narrower than the technical debate. It will have to assess whether Garmin’s marketing claims, disclaimers, and product representations could mislead a reasonable consumer, and whether the alleged inaccuracies mattered to purchasing decisions.
MLXIO analysis: The plaintiff does not need to prove that BIA is worthless. A stronger theory is that Garmin’s presentation allegedly blurred the line between “useful trend estimate” and “accurate body-composition measurement.” That is a more dangerous claim for any connected-health product maker.
The hard question for connected health devices is how an estimate gets sold
The Garmin case fits a broader product-design tension, but the supplied source supports only a narrow version of that point: the more indirect the measurement, the more careful the claim needs to be.
A scale can directly measure weight. Body fat percentage is different. Notebookcheck’s source material emphasizes that exact body-fat analysis is difficult, even when using more involved methods. DEXA requires specialized equipment. Calipers are easier for private individuals but still produce deviations.
That makes the Index S2 dispute less about whether smart scales should exist and more about how confidently their outputs are framed. If a device’s method is structurally limited to a lower-body electrical path, marketing that suggests accurate whole-body analysis invites scrutiny.
The same trust problem appears across consumer tech whenever product claims outrun what users can verify. MLXIO has covered that theme in other contexts, including DuckDuckGo Grabs iPhone Users as Google AI Search Spooks, where user confidence in technical systems becomes part of the product story. Garmin’s case is narrower, but the consumer-trust logic rhymes.
Smart-scale buyers should treat body composition as a trend line, not a verdict
For Index S2 owners and smart-scale buyers, the practical reading is simple: body-composition numbers from foot-only BIA should be treated as directional estimates, not precise whole-body measurements.
That does not mean ignoring the data. It means using it in the way the measurement principle can better support.
A safer interpretation framework:
- Trend: Watch longer-term movement rather than one reading.
- Context: Remember that a foot-to-foot path is not a full-body scan.
- Comparison: Do not treat a consumer scale as equivalent to DEXA.
- Decisions: Avoid making major health or training decisions from the scale’s body-composition output alone.
For Garmin and similar brands, the prescription is also clear: separate measured values from inferred values. If the product outputs body-composition metrics, label them in language that reflects the method’s limits. If there is validation data, make the comparison method and error range easy to find.
The next test is whether clearer labels become cheaper than litigation
The lawsuit can still end several ways: dismissal, settlement, or a court fight over Garmin’s marketing and the technical evidence in the complaint. None of those outcomes is established yet.
The near-term signal to watch is whether Garmin changes how it describes the Index S2 or similar smart-scale metrics. A stronger label would distinguish direct measurement from modeled estimate. A weaker response would keep the marketing language intact and leave the court to decide whether that language crossed the line.
Evidence that would support the plaintiff’s thesis would include court findings that Garmin’s accuracy claims created unreasonable consumer expectations, or that the alleged discrepancies were material. Evidence that would weaken it would include clear disclosures, defensible validation, or a ruling that reasonable buyers understood the scale’s limits.
For connected fitness brands, the lesson is already visible: more metrics are not always the competitive edge. Sometimes the more valuable feature is proof of what the metric can—and cannot—show.
Impact Analysis
- The case could affect how fitness-tech companies describe estimated health metrics.
- Consumers may rely on smart-scale readings for health decisions despite technical limitations.
- The lawsuit tests whether modeled outputs can be marketed as accurate measurements.
